Drugs / AEC/BC02
AEC/BC02
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03026972 | Apr → Sep 2018 | tuberculosis | Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AEC/BC02 | “Recombinant Mycobacterium tuberculosis Vaccine Freeze-dried (AEC/BC02)” NCT03026972 ↗ |
| Known as | Recombinant Mycobacterium tuberculosis Vaccine Freeze-dried | “Recombinant Mycobacterium tuberculosis Vaccine Freeze-dried (AEC/BC02)” NCT03026972 ↗ |
| Modality | Vaccine | “Recombinant Mycobacterium tuberculosis Vaccine Freeze-dried” NCT03026972 ↗ |
| Route | Intramuscular | “Population I are coxal muscle injection of placebo or low dose adjuvant or low dose vaccine.” NCT03026972 ↗ |